Davenport & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
SMDAM
CRM
SW
Davenport & Co's AMGN Position: Q2 2026 in Review
Davenport & Co reduced its Amgen (AMGN) stake by 0.75% in Q2 2026, selling an estimated $149K and leaving 57,790 shares worth $20.9M. The position accounts for 0.1% of the portfolio, ranked #169.
Davenport & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $44.2M in Q3 2014. 851 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Davenport & Co held 57,790 shares of Amgen worth $20.9M as of Q2 2026.
- Davenport & Co sold 436 Amgen shares in Q2 2026, an estimated $149K.
- Amgen made up 0.1% of Davenport & Co's portfolio in Q2 2026, its #169 holding.
- Davenport & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- Davenport & Co's Amgen position peaked at $44.2M in Q3 2014.
- 851 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.